Deleersnijder A - Search Results

1

Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology.

Gerard M, Deleersnijder A, Daniëls V, Schreurs S, Munck S, Reumers V, Pottel H, Engelborghs Y, Van den Haute C, Taymans JM, Debyser Z, Baekelandt V. Gerard M, et al. Among authors: deleersnijder a. J Neurosci. 2010 Feb 17;30(7):2454-63. doi: 10.1523/JNEUROSCI.5983-09.2010. J Neurosci. 2010. PMID: 20164329 Free PMC article.

2

Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration.

Gerard M, Deleersnijder A, Demeulemeester J, Debyser Z, Baekelandt V. Gerard M, et al. Among authors: deleersnijder a. Mol Neurobiol. 2011 Aug;44(1):13-27. doi: 10.1007/s12035-011-8184-2. Epub 2011 May 7. Mol Neurobiol. 2011. PMID: 21553017 Review.

3

Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of alpha-synuclein aggregation.

Deleersnijder A, Van Rompuy AS, Desender L, Pottel H, Buée L, Debyser Z, Baekelandt V, Gerard M. Deleersnijder A, et al. J Biol Chem. 2011 Jul 29;286(30):26687-701. doi: 10.1074/jbc.M110.182303. Epub 2011 Jun 7. J Biol Chem. 2011. PMID: 21652707 Free PMC article.

4

The remarkable conformational plasticity of alpha-synuclein: blessing or curse?

Deleersnijder A, Gerard M, Debyser Z, Baekelandt V. Deleersnijder A, et al. Trends Mol Med. 2013 Jun;19(6):368-77. doi: 10.1016/j.molmed.2013.04.002. Epub 2013 May 3. Trends Mol Med. 2013. PMID: 23648364 Review.

5

Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice.

Oliveras-Salvá M, Macchi F, Coessens V, Deleersnijder A, Gérard M, Van der Perren A, Van den Haute C, Baekelandt V. Oliveras-Salvá M, et al. Among authors: deleersnijder a. Neurobiol Aging. 2014 Nov;35(11):2625-2636. doi: 10.1016/j.neurobiolaging.2014.04.032. Epub 2014 Jun 14. Neurobiol Aging. 2014. PMID: 25037286

6

High-content analysis of α-synuclein aggregation and cell death in a cellular model of Parkinson's disease.

Macchi F, Deleersnijder A, Van den Haute C, Munck S, Pottel H, Michiels A, Debyser Z, Gerard M, Baekelandt V. Macchi F, et al. Among authors: deleersnijder a. J Neurosci Methods. 2016 Mar 1;261:117-27. doi: 10.1016/j.jneumeth.2015.11.009. Epub 2015 Nov 24. J Neurosci Methods. 2016. PMID: 26620202

7

In vitro DNA tethering of HIV-1 integrase by the transcriptional coactivator LEDGF/p75.

McNeely M, Hendrix J, Busschots K, Boons E, Deleersnijder A, Gerard M, Christ F, Debyser Z. McNeely M, et al. Among authors: deleersnijder a. J Mol Biol. 2011 Jul 29;410(5):811-30. doi: 10.1016/j.jmb.2011.03.073. J Mol Biol. 2011. PMID: 21763490

8

Conducting Non-COVID-19 Clinical Trials during the Pandemic: Can Today's Learning Impact Framework Efficiency?

Lalova T, Negrouk A, Deleersnijder A, Valcke P, Huys I. Lalova T, et al. Among authors: deleersnijder a. Eur J Health Law. 2020 Oct 21;27(5):425-450. doi: 10.1163/15718093-BJA10031. Eur J Health Law. 2020. PMID: 33652387

9

Implementation of Regulation (EU) No 536/2014 as a Non-commercial Sponsor: An Internal Survey and a Descriptive Analysis of Timelines.

Stans J, Verbandt S, Kromar S, Deleersnijder A. Stans J, et al. Among authors: deleersnijder a. Ther Innov Regul Sci. 2023 Sep;57(5):1113-1120. doi: 10.1007/s43441-023-00553-x. Epub 2023 Jun 30. Ther Innov Regul Sci. 2023. PMID: 37389794

10

Will molecular target agents enable the multidisciplinary treatment in stage IV gastric cancer?

Kataoka K, Deleersnijder A, Lordick F. Kataoka K, et al. Among authors: deleersnijder a. Eur J Surg Oncol. 2017 Oct;43(10):1835-1845. doi: 10.1016/j.ejso.2017.08.006. Epub 2017 Aug 30. Eur J Surg Oncol. 2017. PMID: 28888797 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters